These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 26248619)

  • 1. Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial.
    Qi WW; Liu T; Xu G; Li LF; Liang YZ; Ye L; Li GP
    Trials; 2015 Aug; 16():336. PubMed ID: 26248619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upstream therapeutic strategies of valsartan and fluvastatin on hypertensive patients with non-permanent atrial fibrillation.
    Zhao Z; Niu X; Dong Z; Qi W; Liu E; Liu T; Li L; Liang Y; Li G
    Cardiovasc Ther; 2018 Dec; 36(6):e12478. PubMed ID: 30390409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial.
    Zhao Z; Yang Y; Wang J; Dong Z; Niu X; Liu E; Liu T; Li L; Liang Y; Li G
    Clin Cardiol; 2020 Dec; 43(12):1592-1600. PubMed ID: 33103770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients.
    Du H; Fan J; Ling Z; Woo K; Su L; Chen S; Liu Z; Lan X; Zhou B; Xu Y; Chen W; Xiao P; Yin Y
    Hypertension; 2013 Apr; 61(4):786-92. PubMed ID: 23438932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.
    Ruggenenti P; Perna A; Tonelli M; Loriga G; Motterlini N; Rubis N; Ledda F; Rota S; Satta A; Granata A; Battaglia G; Cambareri F; David S; Gaspari F; Stucchi N; Carminati S; Ene-Iordache B; Cravedi P; Remuzzi G;
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):1928-38. PubMed ID: 20671225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P; Gianfranchi L; Pacchioni F
    G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H
    J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
    Yamashita T; Inoue H; Okumura K; Kodama I; Aizawa Y; Atarashi H; Ohe T; Ohtsu H; Kato T; Kamakura S; Kumagai K; Kurachi Y; Koretsune Y; Saikawa T; Sakurai M; Sato T; Sugi K; Nakaya H; Hirai M; Hirayama A; Fukatani M; Mitamura H; Yamazaki T; Watanabe E; Ogawa S;
    Europace; 2011 Apr; 13(4):473-9. PubMed ID: 21148662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.
    Disertori M; Franzosi MG; Barlera S; Cosmi F; Quintarelli S; Favero C; Cappellini G; Fabbri G; Maggioni AP; Staszewsky L; Moroni LA; Latini R;
    BMC Cardiovasc Disord; 2013 Apr; 13():28. PubMed ID: 23586654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
    Disertori M; Lombardi F; Barlera S; Maggioni AP; Favero C; Franzosi MG; Lucci D; Staszewsky L; Fabbri G; Quintarelli S; Bianconi L; Latini R
    Am Heart J; 2011 Aug; 162(2):382-9. PubMed ID: 21835301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial remodeling and response to valsartan in the prevention of recurrent atrial fibrillation: the GISSI-AF echocardiographic substudy.
    Staszewsky L; Wong M; Masson S; Raimondi E; Gramenzi S; Proietti G; Bicego D; Emanuelli C; Pulitanò G; Taddei F; Nicolis EB; Correale E; Fabbri G; Bertocchi F; Franzosi MG; Maggioni AP; Tognoni G; Disertori M; Latini R;
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):721-8. PubMed ID: 21926261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Lehto M; Gerdts E; Olsen MH; Hornestam B; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):712-9. PubMed ID: 15734615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.
    Okin PM; Bang CN; Wachtell K; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):243-51. PubMed ID: 23403268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.
    Schmieder RE; Kjeldsen SE; Julius S; McInnes GT; Zanchetti A; Hua TA;
    J Hypertens; 2008 Mar; 26(3):403-11. PubMed ID: 18300848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence.
    Disertori M; Latini R; Maggioni AP; Delise P; Di Pasquale G; Franzosi MG; Staszewsky L; Tognoni G;
    J Cardiovasc Med (Hagerstown); 2006 Jan; 7(1):29-38. PubMed ID: 16645357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of valsartan, fluvastatin extended release and their combination on arterial pressure, parameters of lipid metabolism, and endothelial function in patients with hypertensive disease].
    Soboleva GN; Pogorelova OA; Kuznetsova TV; Masenko VP; Fomicheva OA; Chernova NA; Rogoza AN; Balakhonova TV; Karpov IuA
    Kardiologiia; 2007; 47(11):9-13. PubMed ID: 18260957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Zoppi A; Mugellini A; Corradi L; Lazzari P; Preti P; Derosa G
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):217-22. PubMed ID: 18356684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.